🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is determine if SCH 530348 2.5 mg tablets contain...
Status
Completed
Location
Multiple Locations
Start Date
2010-08
Trial ID
NCT01358344
Treatments Being Tested
ADVICE is a randomised, international, double-blind, placebo-controlled tri...
Status
Completed
Location
Georgetown University Hospital
Start Date
2015-09
Trial ID
NCT02394730
This investigation will be conducted in patients 18-75 years of age with mu...
Status
Completed
Location
Inova Fairfax Hospital
Start Date
2016-01-01
Trial ID
NCT03207451
Treatments Being Tested
This study is designed to evaluate the long-term ocular safety of SCH 53034...
Status
Completed
Location
Multiple Locations
Start Date
2008-07-01
Trial ID
NCT00617123
Treatments Being Tested
The study is designed to assess safety and effects of vorapaxar, when added...
Status
Completed
Location
Multiple Locations
Start Date
2006-12-01
Trial ID
NCT00684203
Treatments Being Tested
Dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 receptor inhibito...
Status
Completed
Location
University of Florida
Start Date
2016-03-25
Trial ID
NCT02548650
Treatments Being Tested
Dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 receptor inhibito...
Status
Completed
Location
University of Florida
Start Date
2016-02
Trial ID
NCT02545933
Treatments Being Tested
The study is designed to assess safety of Vorapaxar when added to standard ...
Status
Completed
Location
Multiple Locations
Start Date
2006-09-21
Trial ID
NCT00684515
Treatments Being Tested
The study is designed to determine whether vorapaxar, when added to the exi...
Status
Completed
Location
Multiple Locations
Start Date
2007-09-01
Trial ID
NCT00526474
The Objectives of this study are: 1. To determine if vorapaxar safely impr...
Status
Completed
Location
Stanford Univeristy
Start Date
2015-08-26
Trial ID
NCT02475837
Treatments Being Tested